Drug recall · August 29, 2018
Valsartan Tablets USP 320 mg recall
Why: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9
- Lots / codes
Lot # G2017F NDC 68788-6882-9
- Quantity
- 9 bottles consisting of 90 tables each bottle
- Company
- Preferred Pharmaceuticals, Inc, Anaheim, CA
- Distribution
- Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.
- Initiated
- August 15, 2018 · Voluntary: Firm initiated
- Classified
- August 17, 2018
- Reported
- August 29, 2018
- Ended
- January 18, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valsartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.